Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
18.8M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
1.5M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$3.74M
-
Value change
-
+$3.74M
-
Number of buys
-
3
-
Price
-
$2.46
Significant Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) as of Q4 2024
3 filings reported holding MDCX - Medicus Pharma Ltd. - Common shares, no par value as of Q4 2024.
Medicus Pharma Ltd. - Common shares, no par value (MDCX) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.5M shares
of 18.8M outstanding shares and own 8.02% of the company stock.
Largest 3 shareholders include Interchange Capital Partners, LLC (1.46M shares), PATRIOT INVESTMENT MANAGEMENT GROUP, INC. (29.1K shares), and Royal Bank of Canada (17.1K shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.